Cellebrite DI (NASDAQ:CLBT) is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.
The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows. Cellebrite DI also provides cloud collection tools to access data stored in online accounts and a suite of analytical modules that facilitate link analysis, timeline reconstruction and cross-case comparison. These solutions are complemented by professional services, training programs and technical support to ensure organizations can deploy and operate the technology effectively.
Founded in 1999 and headquartered in Petah Tikva, Israel, Cellebrite DI maintains key regional offices in North America, EMEA and APAC to serve a diverse global customer base. The company has played a role in high-profile forensic investigations, compliance audits and cybersecurity operations across multiple continents. Over time, it has expanded its portfolio through targeted research and development, strategic partnerships and acquisitions aimed at advancing its digital intelligence capabilities and addressing emerging challenges in data privacy and security.
Under the leadership of President and Chief Executive Officer Yossi Carmil, Cellebrite DI is governed by a board of directors chaired by cybersecurity veteran Amit Yoran. The management team combines expertise in digital forensics, software engineering and law enforcement to drive product innovation and maintain rigorous standards for data integrity and chain of custody. Through ongoing investment in R&D and a focus on customer-centric solutions, Cellebrite DI continues to evolve its offering to meet the needs of investigators and risk-management professionals worldwide.
